comprehensive -WSS

comprehensive

author：focus 2025-09-06 04:42:05 - browse：1178

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Infectious disease expert Jeanne Marrazzo assumes Fauci role

WSS

Evacuations in place as 3 wildfires burn in eastern Washington state

Hilary may become 1st tropical storm to make landfall in California in 84 years

Trump's false claims about Georgia's 2020 election long debunked

Beware the threat of staffing cuts at the CDC

ProMED sees offers of support, but its future remains unclear

Hilary may become 1st tropical storm to make landfall in California in 84 years

focus

comprehensive

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Patient advocates sound warning on FDA proposal on salt intake

Cancer drug shortages should be causing more outrage

Amazon expands telehealth clinic nationwide

Psychedelics group wrestles with new pharma identity

Clinical trials must include more disabled people

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Supreme Court strikes down use of affirmative action

What the US credit downgrade means for the economy, your finances

knowledge

National panel will explore requiring free Covid tests

EQRx, failed developer of low

Living with Hashimoto's and celiac disease, and med school, too

Patient advocates sound warning on FDA proposal on salt intake

Trump indictment: Who are the 'co

ActiGraph execs on goal of drug approvals with digital endpoints

knowledge

focus

hotspot

leisure time